Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
Kozumi, Kazuhiro, Kodama, Takahiro, Murai, Hiroki, Sakane, Sadatsugu, Govaere, Olivier, Cockell, Simon, Motooka, Daisuke, Kakita, Naruyasu, Yamada, Yukinori, Kondo, Yasuteru, Tahata, Yuki, Yamada, Ryoko, Hikita, Hayato, Sakamori, Ryotaro, Kamada, Yoshihiro, Daly, Ann K., Anstee, Quentin M., Tatsumi, Tomohide, Morii, Eiichi, Takehara, Tetsuo
Published in Hepatology (Baltimore, Md.) (01.11.2021)
Published in Hepatology (Baltimore, Md.) (01.11.2021)
Get full text
Journal Article
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma
Maesaka, Kazuki, Sakamori, Ryotaro, Yamada, Ryoko, Doi, Akira, Tahata, Yuki, Miyazaki, Masanori, Ohkawa, Kazuyoshi, Mita, Eiji, Iio, Sadaharu, Nozaki, Yasutoshi, Yakushijin, Takayuki, Imai, Yasuharu, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Hepatology research (01.07.2022)
Published in Hepatology research (01.07.2022)
Get full text
Journal Article
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery
Sakamori, Ryotaro, Yamada, Ryoko, Tahata, Yuki, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Yamada, Tomomi, Takehara, Tetsuo
Published in Journal of gastroenterology (01.02.2022)
Published in Journal of gastroenterology (01.02.2022)
Get full text
Journal Article
Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
Maesaka, Kazuki, Sakamori, Ryotaro, Yamada, Ryoko, Tahata, Yuki, Imai, Yasuharu, Ohkawa, Kazuyoshi, Miyazaki, Masanori, Mita, Eiji, Ito, Toshifumi, Hagiwara, Hideki, Yakushijin, Takayuki, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Hepatology research (01.03.2022)
Published in Hepatology research (01.03.2022)
Get full text
Journal Article
Treatment progress and expansion in Japan: From interferon to direct-acting antiviral
Tahata, Yuki, Sakamori, Ryotaro, Takehara, Tetsuo
Published in Global Health & Medicine (31.10.2021)
Published in Global Health & Medicine (31.10.2021)
Get full text
Journal Article
Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
Shirai, Kumiko, Hikita, Hayato, Sakane, Sadatsugu, Narumi, Ryohei, Adachi, Jun, Doi, Akira, Tanaka, Satoshi, Tahata, Yuki, Yamada, Ryoko, Kodama, Takahiro, Sakamori, Ryotaro, Tatsumi, Tomohide, Mita, Eiji, Tomonaga, Takeshi, Takehara, Tetsuo
Published in PloS one (07.07.2022)
Published in PloS one (07.07.2022)
Get full text
Journal Article
Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis
Sakamori, Ryotaro, Yamada, Ryoko, Shinkai, Kazuma, Doi, Akira, Tahata, Yuki, Shigekawa, Minoru, Kodama, Takahiro, Hikita, Hayato, Yamada, Tomomi, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Internal Medicine (01.03.2021)
Published in Internal Medicine (01.03.2021)
Get full text
Journal Article
Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma
Maesaka, Kazuki, Sakamori, Ryotaro, Yamada, Ryoko, Tahata, Yuki, Urabe, Ayako, Shigekawa, Minoru, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Hepatology research (01.03.2020)
Published in Hepatology research (01.03.2020)
Get full text
Journal Article
Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review
Sung, Ji Hyun, Sakamori, Ryotaro, Yamada, Ryoko, Yoshioka, Teppei, Sakane, Sadatsugu, Tahata, Yuki, Shigekawa, Minoru, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Internal Medicine (01.05.2022)
Published in Internal Medicine (01.05.2022)
Get full text
Journal Article
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
Tahata, Yuki, Hikita, Hayato, Mochida, Satoshi, Kawada, Norifumi, Enomoto, Nobuyuki, Ido, Akio, Yoshiji, Hitoshi, Miki, Daiki, Hiasa, Yoichi, Takikawa, Yasuhiro, Sakamori, Ryotaro, Kurosaki, Masayuki, Yatsuhashi, Hiroshi, Tateishi, Ryosuke, Ueno, Yoshiyuki, Itoh, Yoshito, Yamashita, Taro, Kanto, Tatsuya, Suda, Goki, Nakamoto, Yasunari, Kato, Naoya, Asahina, Yasuhiro, Matsuura, Kentaro, Terai, Shuji, Nakao, Kazuhiko, Shimizu, Masahito, Takami, Taro, Akuta, Norio, Yamada, Ryoko, Kodama, Takahiro, Tatsumi, Tomohide, Yamada, Tomomi, Takehara, Tetsuo
Published in Journal of gastroenterology (2021)
Published in Journal of gastroenterology (2021)
Get full text
Journal Article
The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis
Sato, Katsuhiko, Hikita, Hayato, Shigekawa, Minoru, Soma, Kazumasa, Yamauchi, Ryohei, Sung, Jihyun, Kato, Seiya, Sasaki, Yoichi, Kudo, Shinnosuke, Fukumoto, Kenji, Shirai, Kumiko, Murai, Kazuhiro, Tahata, Yuki, Yoshioka, Teppei, Nishio, Akira, Saito, Yoshinobu, Kodama, Takahiro, Sasaki, Yutaka, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Scientific reports (26.05.2024)
Published in Scientific reports (26.05.2024)
Get full text
Journal Article
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
Maesaka, Kazuki, Sakamori, Ryotaro, Yamada, Ryoko, Doi, Akira, Tahata, Yuki, Ohkawa, Kazuyoshi, Oshita, Masahide, Miyazaki, Masanori, Yakushijin, Takayuki, Nozaki, Yasutoshi, Matsumoto, Kengo, Tanaka, Satoshi, Kaneko, Akira, Iio, Sadaharu, Nawa, Takatoshi, Yamada, Yukinori, Morishita, Naoki, Usui, Takeo, Hiramatsu, Naoki, Doi, Yoshinori, Sakakibara, Mitsuru, Imanaka, Kazuho, Yoshida, Yuichi, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Published in PloS one (07.02.2023)
Published in PloS one (07.02.2023)
Get full text
Journal Article
Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination
Myojin, Yuta, Hikita, Hayato, Tahata, Yuki, Doi, Akira, Kato, Seiya, Sasaki, Yoichi, Shirai, Kumiko, Sakane, Sadatsugu, Yamada, Ryoko, Kodama, Takahiro, Hagiwara, Hideki, Imai, Yasuharu, Hiramatsu, Naoki, Tamura, Shinji, Yamamoto, Keiji, Ohkawa, Kazuyoshi, Hijioka, Taizo, Fukui, Hiroyuki, Doi, Yoshinori, Yamada, Yukinori, Yakushijin, Takayuki, Mita, Eiji, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Alimentary pharmacology & therapeutics (01.02.2022)
Published in Alimentary pharmacology & therapeutics (01.02.2022)
Get full text
Journal Article
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study
Kai, Machiko, Hikita, Hayato, Kazuki, Maesaka, Tahata, Yuki, Shinkai, Kazuma, Doi, Akira, Ohkawa, Kazuyoshi, Miyazaki, Masanori, Ishida, Hisashi, Matsumoto, Kengo, Nozaki, Yasutoshi, Yakushijin, Takayuki, Sakamori, Ryotaro, Kaneko, Akira, Iio, Sadaharu, Nawa, Takatoshi, Kakita, Naruyasu, Morishita, Naoki, Hiramatsu, Naoki, Usui, Takeo, Imanaka, Kazuho, Doi, Yoshinori, Sakakibara, Mitsuru, Yoshida, Yuichi, Oze, Tsugiko, Kodama, Takahiro, Tatsumi, Tomohide, Takehara, Tetsuo
Published in PloS one (02.01.2024)
Published in PloS one (02.01.2024)
Get full text
Journal Article
Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller
Takigawa, Atsuo, Sakamori, Ryotaro, Tahata, Yuki, Yoshioka, Teppei, Yamada, Ryoko, Kodama, Takahiro, Hikita, Hayato, Yakushijin, Takayuki, Ohkawa, Kazuyoshi, Hiramatsu, Naoki, Mita, Eiji, Hagiwara, Hideki, Ito, Toshifmi, Imai, Yasuharu, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Digestive diseases and sciences (01.12.2022)
Published in Digestive diseases and sciences (01.12.2022)
Get full text
Journal Article
Initial treatment response to transarterial chemoembolization as a predictive factor for Child–Pugh class deterioration prior to refractoriness in hepatocellular carcinoma
Maesaka, Kazuki, Sakamori, Ryotaro, Yamada, Ryoko, Tahata, Yuki, Imai, Yasuharu, Oshita, Masahide, Ohkawa, Kazuyoshi, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Hepatology research (01.11.2020)
Published in Hepatology research (01.11.2020)
Get full text
Journal Article
Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis
Shirai, Kumiko, Hikita, Hayato, Sakamori, Ryotaro, Doi, Akira, Tahata, Yuki, Sakane, Sadatsugu, Kamada, Yoshihiro, Murai, Kazuhiro, Nishio, Akira, Yamada, Ryoko, Kodama, Takahiro, Nozaki, Yasutoshi, Kakita, Naruyasu, Ishida, Hisashi, Nakanishi, Fumihiko, Morishita, Naoki, Imanaka, Kazuho, Sakakibara, Mitsuru, Tatsumi, Tomohide, Miyoshi, Eiji, Takehara, Tetsuo
Published in PloS one (21.12.2022)
Published in PloS one (21.12.2022)
Get full text
Journal Article
Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment
Tahata, Yuki, Sakamori, Ryotaro, Urabe, Ayako, Yamada, Ryoko, Ohkawa, Kazuyoshi, Hiramatsu, Naoki, Hagiwara, Hideki, Oshita, Masahide, Imai, Yasuharu, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Hepatology research (01.10.2020)
Published in Hepatology research (01.10.2020)
Get full text
Journal Article
Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma
Maesaka, Kazuki, Sakamori, Ryotaro, Yamada, Ryoko, Tahata, Yuki, Ohkawa, Kazuyoshi, Oshita, Masahide, Tamura, Shinji, Hagiwara, Hideki, Mita, Eiji, Yakushijin, Takayuki, Inada, Masami, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Anticancer research (01.04.2021)
Published in Anticancer research (01.04.2021)
Get full text
Journal Article
Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection
Doi, Akira, Hikita, Hayato, Sakamori, Ryotaro, Tahata, Yuki, Kai, Yugo, Yamada, Ryoko, Yakushijin, Takayuki, Mita, Eiji, Ohkawa, Kazuyoshi, Imai, Yasuharu, Furuta, Kunimaro, Kodama, Takahiro, Tatsumi, Tomohide, Takehara, Tetsuo
Published in Hepatology (Baltimore, Md.) (01.07.2018)
Published in Hepatology (Baltimore, Md.) (01.07.2018)
Get full text
Journal Article